CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma

Marc Gauthier, Sagar Laxman Kale, Timothy B. Oriss, Michael Gorry, Richard P. Ramonell, Kathryn Dalton, Prabir Ray, John V. Fahy, Max A. Seibold, Mario Castro, Nizar Jarjour, Benjamin Gaston, Eugene R. Bleecker, Deborah A. Meyers, Wendy Moore, Annette T. Hastie, Elliot Israel, Bruce D. Levy, David Mauger, Serpil ErzurumSuzy A. Comhair, Sally E. Wenzel, Anuradha Ray

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma'. Together they form a unique fingerprint.

Medicine & Life Sciences